{"name":"Arno Therapeutics","slug":"arno-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":8653008,"netIncome":-11507963,"cash":361240,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9scjV0TVA3bVgtNFVSbEpnSHI1TDBQMTl5VU1zU3NYQWtiMmNrTVh2QV9xdEpLckI5a1VXcFlia2psdWtVbzRrX3JPOFlZYkYtUk5n?oc=5","date":"2026-02-09","type":"deal","source":"FirstWord Pharma","summary":"Biopharma bites: Aerska, Galux add new funds while Vesalic makes its debut, plus CSL and Memo's IgG deal - FirstWord Pharma","headline":"Biopharma bites: Aerska, Galux add new funds while Vesalic makes its debut, plus CSL and Memo's IgG deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxQVEZPaVhFeDdVR0dFWWZjWkZsSnBiSzJZU1RDdmtLcDZaejZQSFpwbTlKaVlILVFLSEhqZnBaZU93ZndWSjNjemI3ZU1TNlpNZExCQUJoWjJEa3F2Ykt1QVkzdWRMX0J4VjNzTjdsak1OVG1YbVJPQTlRR3VRVElUYjNGNFl6ZEhZLVU4YUJfQTNncGNDSE5CRFNhOWlsYzhMWmNBV2h1ZFRWYmRRdEt0eDRGeDZrTmhHRG8xcWJtaGxMTnVKb21OZE03SmUxV29wS2ZHdzl0a2lhaW5TWTNHcnVPLURkX19mUGZlbGlUNXNNbEREZ003RXR1TGo5S1RpcU1LZy1Dd0dGdUNPdktYM0tDNXJ6dnVJOF9EcmtlUUVsYkNEOUc2cldtZTlKaExKYkVkR3gwT1hHZw?oc=5","date":"2025-02-26","type":"pipeline","source":"GlobeNewswire","summary":"Idorsia reaches an agreement with significant bondholders - GlobeNewswire","headline":"Idorsia reaches an agreement with significant bondholders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOX21SLWt6NTBSbmtoLVotaEk1Y3VDLVNPNkNlX2VURE42clhmXzFfZFBRN3ZGdndfeklpWWdvbEppT3lkMVdOSWRwOG9LQkFnXzd4b0FUNzJvWldfQzduM1FxSDJfRWhMTXNtWkJ0V0FWU2xhSXUzUmVOUGd0UjFPRFlyZ3B1UjdsdzVpVkRkOFpwU1ZfclhxZQ?oc=5","date":"2022-05-27","type":"pipeline","source":"The Business Journals","summary":"How Arie Belldegrun is still charting his path to serial success - The Business Journals","headline":"How Arie Belldegrun is still charting his path to serial success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE5CS0ljdGdVNVJpVEZZZ1hlQkxteWd1SjJJTGwxWDRwRTBMbUNPWl8yZmV0NHp3MU9sSVFlWDczbjRIdFpWa3R2SV8tRFdudWE5bzV4UzFRUGdXMFhnUDZfR0daY1YzVElkRllLMngwZw?oc=5","date":"2017-12-22","type":"pipeline","source":"BioSpace","summary":"Arno Therapeutics Is Shuttering Its Doors - BioSpace","headline":"Arno Therapeutics Is Shuttering Its Doors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1SMnRhcHoxQUo3dEQzaHlhSUJMS181a2kyajRxcWxORmxJWS02R1RtMFMxcmxESTRCQ0J5cnRnSnZSTkZ6MHJmTFpNby1ZcTlEejg3MHZuYkhjQzZJR0wtTFFTdXpVNENTcmhoUzYycWV3WDY5cG9j?oc=5","date":"2017-08-30","type":"pipeline","source":"CTech","summary":"Meet Kite Pharma's CEO, the Man Bringing Hope to Hodgkin's Lymphoma Patients - CTech","headline":"Meet Kite Pharma's CEO, the Man Bringing Hope to Hodgkin's Lymphoma Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBNaVl2VnRFS0Z4WHhKdkYzNENOZ1NOTUZjZzVmMGxRakNOb256XzdtQlFJTVhJYU5jWlN6ZkFxR1piRW5HRVk5LWN1UDVkWUQzX3RiSk4yLU5vcFFMUTRyMnRKZmNiaFd4c3o0cWxpTWd5WjhpLXNPRExB?oc=5","date":"2017-08-11","type":"pipeline","source":"labusinessjournal.com","summary":"LA 500: Arie Belldegrun - labusinessjournal.com","headline":"LA 500: Arie Belldegrun","sentiment":"neutral"},{"date":"2017-01-09","type":"earnings","source":"SEC EDGAR","summary":"SC 13D filed with SEC","headline":"SC 13D Filing","sentiment":"neutral"},{"date":"2016-11-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOM0N2OWc2MUJ0cmRFRHBybW5oSU1Mb2NmalF6SkkwTlNJWFZQbnQzVHNSckV4UlF0N3VQazdGSkxkNnExVlZ1M0R4Mk1EQWI0X2diRS1mcUlMRU9zWHNTZU5vcHlvYUgzc1JqWU9sY2dKYy1DS2JLWkhwMnNzaGZHQWN0QVQwTXlsV1RBUnFvb1gxTFM5cHJpSw?oc=5","date":"2013-02-18","type":"pipeline","source":"BioSpectrum Asia","summary":"Teva appoints Arie Belldegrun to its board - BioSpectrum Asia","headline":"Teva appoints Arie Belldegrun to its board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9sS3ZKYUI5UGdRLWc4YmxBMjFzTjE2SnE3ZERNTFlqaFYxRE12WTVMZ05LMDFNQU5ZYzR4eXV1bmZqUUNxdGcwNUhja2xCMFd3SEhBRlZXcDVSY0JwQ254M1pWVzBUR1ZBLXZpWA?oc=5","date":"2011-07-26","type":"pipeline","source":"Pharma Voice","summary":"Talent Pool - Pharma Voice","headline":"Talent Pool","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":8653008,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-11507963,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":361240,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}